[go: up one dir, main page]

BR0314878A - Derivados de [1,4] benzodioxino[2,3-e] isoindol substituìdos, seu processo de preparo e as composições farmacêuticas que os contêm - Google Patents

Derivados de [1,4] benzodioxino[2,3-e] isoindol substituìdos, seu processo de preparo e as composições farmacêuticas que os contêm

Info

Publication number
BR0314878A
BR0314878A BR0314878-5A BR0314878A BR0314878A BR 0314878 A BR0314878 A BR 0314878A BR 0314878 A BR0314878 A BR 0314878A BR 0314878 A BR0314878 A BR 0314878A
Authority
BR
Brazil
Prior art keywords
straight
group
branched
benzodioxino
hydrogen atom
Prior art date
Application number
BR0314878-5A
Other languages
English (en)
Inventor
Gerard Coudert
Nathalie Ayerbe
Frank Lepifre
Sylvain Routier
Daniel Henri Caignard
Pierre Renard
John Hickman
Alain Pierre
Stephane Leonce
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BR0314878A publication Critical patent/BR0314878A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"DERIVADOS DE [1,4]BENZODIOXINO[2,3-e]ISOINDOL SUBSTITUìDOS, SEU PROCESSO DE PREPARO E AS COMPOSIçõES FARMACêUTICAS QUE OS CONTêM". Compostos de fórmula (I), na qual: A é tal como definido na descrição, Y representa um grupamento escolhido dentre o átomo de oxigênio ou grupamento metileno, R~ 2~ representa um átomo de hidrogênio, e nesse caso R~ 3~ representa um grupamento escolhido dentre um átomo de hidrogênio, grupamento alquila (C~ 1~-C~ 6~), linear ou ramificado, arila, arilalquila (C~ 1~-C~ 6~), linear ou ramificado, ou SO~ 2~ CF~ 3~, ou bem R~ 2~ e R~ 3~ formam uma ligação, R~ 1~, representa um grupamento escolhido dentre o átomo de hidrogênio, grupamento alquila (C~ 1~-C~ 6~), linear ou ramificado, arila, arilalquila (C~ 1~-C~ 6~), linear ou ramificado, ou uma cadeia alquileno (C~ 1~-C~ 6~), linear ou ramificado, Z~ 1~ e Z~ 1~ e Z~ 2~ representam, cada um, um átomo de hidrogênio ou Z~ 1~, e Z~ 2~ formam juntos com os átomos de carbono que os portam, um grupamento fenila. Medicamentos.
BR0314878-5A 2002-10-18 2003-10-17 Derivados de [1,4] benzodioxino[2,3-e] isoindol substituìdos, seu processo de preparo e as composições farmacêuticas que os contêm BR0314878A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0212965A FR2845997B1 (fr) 2002-10-18 2002-10-18 Nouveaux derives de[1,4]benzodioxino[2,3-e]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2003/003069 WO2004037831A1 (fr) 2002-10-18 2003-10-17 NOUVEAUX DERIVES DE [1,4]BENZODIOXINO[2,3-e]ISOINDOLE SUBSTITUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (1)

Publication Number Publication Date
BR0314878A true BR0314878A (pt) 2005-08-02

Family

ID=32050502

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314878-5A BR0314878A (pt) 2002-10-18 2003-10-17 Derivados de [1,4] benzodioxino[2,3-e] isoindol substituìdos, seu processo de preparo e as composições farmacêuticas que os contêm

Country Status (28)

Country Link
US (1) US7202255B2 (pt)
EP (1) EP1587810B1 (pt)
JP (1) JP2006507280A (pt)
KR (1) KR100695600B1 (pt)
CN (1) CN100412076C (pt)
AR (1) AR041654A1 (pt)
AT (1) ATE344800T1 (pt)
AU (1) AU2003301532A1 (pt)
BR (1) BR0314878A (pt)
CA (1) CA2502488A1 (pt)
CY (1) CY1105972T1 (pt)
DE (1) DE60309605T2 (pt)
DK (1) DK1587810T3 (pt)
EA (1) EA008498B1 (pt)
ES (1) ES2276160T3 (pt)
FR (1) FR2845997B1 (pt)
GE (1) GEP20074102B (pt)
MA (1) MA27340A1 (pt)
MX (1) MXPA05004113A (pt)
MY (1) MY136142A (pt)
NO (1) NO20052330D0 (pt)
NZ (1) NZ539195A (pt)
PL (1) PL375956A1 (pt)
PT (1) PT1587810E (pt)
SI (1) SI1587810T1 (pt)
UA (1) UA79997C2 (pt)
WO (1) WO2004037831A1 (pt)
ZA (1) ZA200502829B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010232646A1 (en) * 2009-03-31 2011-10-20 Arqule, Inc. Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
CN103086947A (zh) * 2011-11-04 2013-05-08 赵庆春 具有抗血管生成活性的邻苯二甲酰亚胺类化合物及其用途
KR101614599B1 (ko) * 2014-04-09 2016-04-21 주식회사 두산 유기 화합물 및 이를 포함하는 유기 전계 발광 소자

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
WO1998009967A1 (fr) * 1996-09-09 1998-03-12 Kyowa Hakko Kogyo Co., Ltd. Derives de pyrrolocarbazole
FR2755691B1 (fr) * 1996-11-08 1998-12-04 Adir Nouveaux derives 7,12-dioxa-benzo[a]anthraceniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2276160T3 (es) 2007-06-16
EP1587810A1 (fr) 2005-10-26
US7202255B2 (en) 2007-04-10
SI1587810T1 (sl) 2007-02-28
DK1587810T3 (da) 2007-03-05
NZ539195A (en) 2007-05-31
ATE344800T1 (de) 2006-11-15
FR2845997A1 (fr) 2004-04-23
KR20050056251A (ko) 2005-06-14
JP2006507280A (ja) 2006-03-02
MA27340A1 (fr) 2005-05-02
WO2004037831A1 (fr) 2004-05-06
NO20052330L (no) 2005-05-12
GEP20074102B (en) 2007-05-10
CA2502488A1 (fr) 2004-05-06
DE60309605T2 (de) 2007-09-27
CY1105972T1 (el) 2011-04-06
KR100695600B1 (ko) 2007-03-14
CN100412076C (zh) 2008-08-20
EA008498B1 (ru) 2007-06-29
US20060040930A1 (en) 2006-02-23
EA200500573A1 (ru) 2005-12-29
CN1705672A (zh) 2005-12-07
EP1587810B1 (fr) 2006-11-08
AU2003301532A1 (en) 2004-05-13
UA79997C2 (en) 2007-08-10
PL375956A1 (en) 2005-12-12
MY136142A (en) 2008-08-29
AR041654A1 (es) 2005-05-26
PT1587810E (pt) 2007-02-28
MXPA05004113A (es) 2005-06-22
FR2845997B1 (fr) 2004-12-24
DE60309605D1 (de) 2006-12-21
ZA200502829B (en) 2006-08-30
NO20052330D0 (no) 2005-05-12

Similar Documents

Publication Publication Date Title
BR9913904A (pt) Produto, medicamento, composição farmacêutica, e, utilização de um produto
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
CO5590897A2 (es) Compuestos heterociclicos que proporcionan agentes farmacologicos que son potentes agonistas de ppars y composiciones farmaceuticas que los contienen
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
CR9602A (es) Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk
AR042273A1 (es) Derivados de pirazol, procedimiento para prepararlos y las composiciones farmaceuticas que los contienen
AR012315A1 (es) Derivados de ditiolan y el uso de los mismos en la fabricacion de un medicamento.
BR9911783A (pt) Compostos cìclicos substituìdos, processo para sua preparação e composições farmacêuticas que os contêm
AR064307A1 (es) Monofosfatos utiles para el tratamiento de la inflamacion pulmonar y broncoconstriccion, formulaciones aerosolicas que los contienen, y metodo de preparacion.
BR9802804A (pt) Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos.
ES2260933T3 (es) Derivados del acido de tiazolina.
BR0003848A (pt) Compostos de piridina, processo para sua preparação e composições farmacêuticas que os contêm
BR0314591A (pt) Métodos de aumento de plaquetas e produção de célula tronco hematopoiética
BR0308765A (pt) Compostos (4,2-dissubstituìdo-tiazol-5-il)amina como inibidores de pde7
BR0313734A (pt) Derivados do tiofeno, o seu processo de preparação e as composições farmacêuticas que os contêm
SE9904421D0 (sv) New compounds
BR9611232A (pt) Antioxidantes contendo grupos fenol e grupos de anima aromática
BR0314878A (pt) Derivados de [1,4] benzodioxino[2,3-e] isoindol substituìdos, seu processo de preparo e as composições farmacêuticas que os contêm
BR9810412A (pt) Desoxiciclodepsipeptìdios e seu emprego para o combate de endoparasitas
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
AR018619A1 (es) Derivados de 8-fenilxantina utiles como inhibidores de fosfoestearasa gmp ciclica (pdes), preparacion, composiciones farmaceuticas formuladas con dichosderivados y uso de dichos derivados para la fabricacion de medicamentos
BRPI0500590B8 (pt) processo para a síntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
DK0807627T3 (da) Anilidforbindelser som ACAT-inhibitorer
BR0104471A (pt) Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
BR0100107A (pt) Compostos de benzenossulfonamida, um processo para sua preparação e composições farmacêuticas que contêm os mesmos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.